Related Experiment Videos
[Cardiac myxoma. Clinical-pathological correlation].
Eduardo D Gabe1, Carlos Rodríguez Correa, Carlos Vigliano
1Departamentos de Cardiología, Instituto de Cardiología y Cirugía Cardiovascular, Fundación Favaloro, Buenos Aires, Argentina. gabe@cardioweb.net.ar
Revista Espanola De Cardiologia
|May 23, 2002
Summary
Cardiac myxomas, common primary heart tumors, often present with constitutional symptoms, dyspnea, or embolism. Higher S phase in tumor DNA may indicate a risk for recurrence.
Area of Science:
- Cardiovascular pathology
- Oncology
- Molecular biology
Context:
- Myxomas are the most common primary cardiac tumors.
- Understanding their clinical presentation and recurrence risk is crucial for patient management.
Purpose:
- To analyze the clinical presentation, postoperative outcomes, and recurrence potential of cardiac myxomas.
- To investigate the relationship between tumor cell cycle (DNA ploidy) and the risk of embolism and recurrence.
Summary:
- This study analyzed 31 cardiac myxoma patients, finding constitutional symptoms, dyspnea, and embolism as frequent manifestations. Smaller tumors correlated with embolism.
- While not statistically significant, a higher proportion of cells in S phase and a higher DNA index were observed in tumors with embolism.
- The single recurrent tumor showed a significantly higher S phase, suggesting it as a potential marker for myxoma recurrence.
Impact:
- Identifies key clinical features and potential risk factors for cardiac myxoma complications.
- Highlights the potential role of cell cycle analysis (S phase) as a predictive marker for myxoma recurrence.
- Informs clinical decision-making regarding diagnosis, surgical management, and long-term surveillance of cardiac myxoma patients.